Dr Alisa Glukhova

Dr Alisa Glukhova



Dr Alisa Glukhova in a laboratory



Dipl. LMSU PhD UofM

Laboratory Head

Lab focus: Structural biology of cell signalling pathways

My laboratory aims to understand the molecular details of cell signalling pathways involved in cell development, fate determination, and polarity. These processes are important in embryonic development and maintenance of healthy tissues in adults. Because of this, their dysregulation underlies the cause of many human cancers. 

By utilising structural biology, biochemistry and biophysics we are trying to understand the atomic-level details of proteins and protein-protein interactions that are involved in signalling events. Such detailed understanding is crucial for the development of novel therapeutics and improving ones that are already in clinical trials.

Research interest

My laboratory is interested in understanding the molecular details of different steps in Wnt pathways. Wnt signalling is initiated by Wnts that bind to their receptors and co-receptors, leading to different cellular responses. Multiple steps of the Wnt pathways have been explored as therapeutic targets for cancer treatment, however, due to the extreme complexity and importance of Wnt signalling for normal tissue homeostasis, its safe and selective targeting remains a challenge.

We are combining cryo-electron microscopy and x-ray crystallography with biochemical, biophysical, and pharmacological assays to gain insights into the atomic-level details of individual proteins as well as large complexes involved in Wnt signal transduction.

Our research interests focus on understanding the initial steps of Wnt signalling cascades. Specifically, we are looking at how Wnt interactions with their receptors and co-receptors lead to signal transmission across the membrane. Another area of interest is the process of Wnt maturation.

Three researchers standing beside a glass wall

Researchers have solved a decade-long mystery about a critical protein linked to Parkinson’s disease that could help to fast-track treatments for the incurable disease.